388 related articles for article (PubMed ID: 9239517)
1. Positive interaction of bisbenzylisoquinoline alkaloid, cepharanthin, with vinca alkaloid agents against human tumors.
Ono M; Tanaka N
In Vivo; 1997; 11(3):233-41. PubMed ID: 9239517
[TBL] [Abstract][Full Text] [Related]
2. Positive interactions between human interferon and cepharanthin against human cancer cells in vitro and in vivo.
Ono M; Tanaka N; Orita K
Cancer Chemother Pharmacol; 1994; 35(1):10-6. PubMed ID: 7527303
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of human recombinant interferon-gamma alone and in combination with adriamycin on a human colon cancer cell line (RPMI 4788) in vitro and in nude mice.
Kondo H; Tanaka N; Orita K
Jpn J Cancer Res; 1987 Dec; 78(12):1400-8. PubMed ID: 3123441
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibition of K-ras-expressing tumours by a new vinca alkaloid, conophylline, in nude mice.
Umezawa K; Taniguchi T; Toi M; Ohse T; Tsutsumi N; Yamamoto T; Koyano T; Ishizuka M
Drugs Exp Clin Res; 1996; 22(2):35-40. PubMed ID: 8879977
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of the new vinca-alkaloid S 12363 alone or in combination with verapamil on a human multidrug resistant renal carcinoma xenograft.
Berlion M; Arvelo F; Leonce S; Bourgeois Y; Rigaudy P; Bizzari JP; Poupon MF
In Vivo; 1993; 7(5):399-405. PubMed ID: 7906553
[TBL] [Abstract][Full Text] [Related]
6. Use of snail neurons in developing quantitative ultrastructural parameters for neurotoxic side effects of Vinca antitumor agents.
Müller LJ; Moorer-van Delft CM; Zijl R; Roubos EW
Cancer Res; 1990 Mar; 50(6):1924-8. PubMed ID: 2407348
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibitory activity of S12363, a novel vinca alkaloid derivative on human melanoma cell lines.
Tolis C; Photiou A; Camplejohn RS; Retsas S
Anticancer Res; 1993; 13(1):161-6. PubMed ID: 8476208
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
9. [Enhancement of the effects of anticancer agents on B16 melanoma cells by combination with cepharanthine--I. Alkaloids].
Kubota R; Kubota K; Yamada S
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2163-7. PubMed ID: 1444481
[TBL] [Abstract][Full Text] [Related]
10. Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells.
Tamatani T; Azuma M; Motegi K; Takamaru N; Kawashima Y; Bando T
Int J Oncol; 2007 Oct; 31(4):761-8. PubMed ID: 17786306
[TBL] [Abstract][Full Text] [Related]
11. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.
Fu L; Liang Y; Deng L; Ding Y; Chen L; Ye Y; Yang X; Pan Q
Cancer Chemother Pharmacol; 2004 Apr; 53(4):349-56. PubMed ID: 14666379
[TBL] [Abstract][Full Text] [Related]
12. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
Beck WT; Cirtain MC; Look AT; Ashmun RA
Cancer Res; 1986 Feb; 46(2):778-84. PubMed ID: 3455678
[TBL] [Abstract][Full Text] [Related]
13. Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells.
Jean-Decoster C; Brichese L; Barret JM; Tollon Y; Kruczynski A; Hill BT; Wright M
Anticancer Drugs; 1999 Jul; 10(6):537-43. PubMed ID: 10885901
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of recombinant human interferon-beta and interferon-gamma in combination against human colon cancer cell line in vitro and in nude mice.
Kondo H; Tanaka N; Naomoto Y; Orita K
Jpn J Cancer Res; 1987 Nov; 78(11):1258-65. PubMed ID: 3121561
[TBL] [Abstract][Full Text] [Related]
15. Preclinical antitumor activity of a new Vinca alkaloid derivative, S 12363.
Pierré A; Kraus-Berthier L; Atassi G; Cros S; Poupon MF; Lavielle G; Berlion M; Bizzari JP
Cancer Res; 1991 May; 51(9):2312-8. PubMed ID: 2015595
[TBL] [Abstract][Full Text] [Related]
16. Re-evaluation of antitumor activity of Cepharanthin.
Terasaka H; Machino M; Saito M; Fujisawa S; Satoh K; Jiang Y; Sakagami H
Anticancer Res; 2002; 22(1A):165-70. PubMed ID: 12017281
[TBL] [Abstract][Full Text] [Related]
17. Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse.
Dorr RT; Alberts DS
J Natl Cancer Inst; 1985 Jan; 74(1):113-20. PubMed ID: 3855472
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and SAR of vinca alkaloid analogues.
Voss ME; Ralph JM; Xie D; Manning DD; Chen X; Frank AJ; Leyhane AJ; Liu L; Stevens JM; Budde C; Surman MD; Friedrich T; Peace D; Scott IL; Wolf M; Johnson R
Bioorg Med Chem Lett; 2009 Feb; 19(4):1245-9. PubMed ID: 19147348
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the pharmacological antitumor effects of S 12363, a new vinca alkaloid.
Atassi G; Berlion M; el Oche Y; Bizzari JP
Anticancer Res; 1991; 11(2):975-80. PubMed ID: 2064354
[TBL] [Abstract][Full Text] [Related]
20. [Antitumor effect of the plant alkaloid preparation, cepharanthin].
Ebina T; Ono M
Gan To Kagaku Ryoho; 2001 Feb; 28(2):211-5. PubMed ID: 11242648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
